Abstract
Autoimmune diseases are thought to result from a dysregulation of the immune system leading to loss of self-tolerance and autoaggression via antigen-specific T and B cell responses. Whether or not these responses are directed against true autoantigens or cross-reacting epitopes of microbial origin remains a matter of intense debate and research (Schwimmbeck et al. 1987; Steglitz et al. 1989; Hermann 1991; Smiley and Hoffmann 1991; Kaufmann 1990). Nevertheless, an ever-increasing number of high-titer autoantibodies of the IgG and IgA isotypes are being reported (Brostoff et al. 1991; Pisetzky 1991). Most of these autoantibodies are associated with distinct clinicopathologic conditions. Thus, various types of antinuclear antibodies (ANA) are specific markers of certain collagen vascular diseases, antimitochondrial antibodies (ANA) are associated with autoimmune liver disease and antineutrophil cytoplasmic autoantibodies (ANA) with necrotizing granulomatous vasculitis or crescentic glomerulonephritis (Jennette and Falk 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balaban EP, Zashin SJ, Geppert TD, Lipsky PE (1991) Treatment of systemic sclerosis with antithymocyte globulin. Arthritis Rheum 34: 244–245
Brooks P (1992) Current issues of methotrexate and cyclosporine. Curr Opin Rheumatol 4: 309–313
Brostoff J, Scadding GK, Male D, Roitt IM (1991) Clinical immunology. Gower Medical, London
Dubois EL (1956) Prednisone and prednisolone in the treatment of systemic lupus erythematosus. JAMA 161: 427–433
Dwyer JM (1992) Manipulation of the immune system with immune globulin. N Engl J Med 326: 107–116
Jeurissen MEC, Toderbooms AM, van de Putte LBA et al. (1991) Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. Arthritis Rheum 34: 961–972
Jennette JC, Falk RJ (1992) Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheumatol 4: 9–15
Hermann E, Lohse AW, Van der Zee R, Van Eden E, Mayet WJ, Probst P, Poralla T, Meyer zum Büschenfelde KH, Fleischer B (1991) Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol 21: 2139–2143
Hofschneider PH, Lemmel EM, Gans W et al. (1992) Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. Rheumatol Int. 12: 175–185
Kalden JR (1985) Plasmapheresis. In: Gupta S, Talal N (eds) Immunology of rheumatic diseases. Plenum Medical, New York, pp 741–765
Kaufmann SHE (1990) Heat shock proteins: a link between rheumatoid arthritis and infection? Curr Opin Rheumatol 2: 430–432
Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Labrum E, Eek M, Mowinkel P, Hovi K, Forre O (1991) Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338: 900–902
Klippel JH (1987) Immunosuppressive therapy. In: Lahita RG (ed) Systemic lupus erythematosus. Wiley, New York, pp 923–945
McCune WJ, Friedman AW (1992) Immunosuppressive drug therapy for rheumatic disease. Curr Opin Rheumatol 4: 314–321
Morell A, Nydegger KE (eds) (1986) Clinical use of intravenous immunoglobulins. Academic, London
Pisetzky DS (1991) Autoantibodies and their idiotypes. Curr Opin Rheumatol 3: 731–737
Reiter C, Kakavand B, Rieber EP, Schattenkirchner M, Riethmüller G, Krüger K (1991) Treatment of rheumatoid arthritis with monoclonal anti CD4 antibody M-T151. Arthritis Rheum 34: 525–536
Rook AH, Freundlich B, Jegasothy BV et al. (1992) Treatment of systemic sclerosis with extracorporeal photochemotherapy — results of a multicenter trial. Arch Dermatol 128: 337–346
Schwimmbeck PL, Yu DT, Oldstone MB (1987) Antibodies to HLA-B27 in the sera of HLA-B27+ patients with ankylosing spondylitis and Reiter’s syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 171: 1635–1647
Skeith KJ, Davies P (1992) New horizons in the medical treatment of rheumatoid arthritis. Curr Opin Rheumatol 4: 365–371
Smiley JD, Hoffmann WL (1991) The role of infections in rheumatic diseases: molecular mimicry between bacterial and human stress proteins. Am J Med Sci 301: 138–149
Steglitz H, Fosmire S, Lipsky P (1989) Identification of a 2-MD from Shigella flexneri plasmid associated with reactive arthritis. Arthritis Rheum 32: 937–946
Strober SM, Farinas EH, Field EH et al. (1988) Treatment of lupus nephritis with total lymphoid irradiation: observations during a 12–79 month follow-up. Arthritis Rheum 31: 850–858
Trentham DE (1992) Novel immunomodulating and immunotherapies and novel therapies and strategies for inflammatory arthropathy. Curr Opin Rheumatol 4: 322–324
Wilske KR, Healey LA (1989) Remodelling the pyramid: a concept whose time has come. J Rheumatol 16: 557–565
Wrouth DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO (1989) Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59: 247–255
Zeidler H, Raspe HH (1990a) Systemische Pharmakotherapie. In: Zeidler H (ed) Rheumatologie. IMG, vol 6. Urban and Schwarzenberg Munich, pp 314–327
Zeidler H, Raspe HH (1990b) Lokale Therapie. In: Zeidler H (ed) Rheumatologie. IMG, vol 6. Urban and Schwarzenberg, Munich, pp 328–334
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Peter, H.H. (1993). Current Principles and Perspectives in the Treatment of Autoimmune Disease. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology I and II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78087-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-78087-5_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56478-2
Online ISBN: 978-3-642-78087-5
eBook Packages: Springer Book Archive